Merit Medical Systems | Beneficio Bruto En Ventas



Gross Profit On Sales Cambio Fecha
3M USD 2.27B 894M 2024-12
Abbott USD 6.03B 93M 2024-12
AtriCure USD 92.62M 5.83M 2024-12
Baxter International USD 1.02B 19M 2024-12
Becton, Dickinson and Co. USD 2.24B 290M 2024-12
Boston Scientific USD 3.1B 194M 2024-12
Cooper Companies USD 660.2M 17.5M 2025-01
Dexcom USD 709.3M 115.5M 2024-12
Edwards Lifesciences USD 1.09B 2.1M 2024-12
Globus Medical USD 393.86M 38.67M 2024-12
Haemonetics USD 196.57M 5.37M 2024-12
Hologic USD 580.5M 22.8M 2024-12
ICU Medical USD 227.26M 22.41M 2024-12
Insulet USD 430.9M 53.8M 2024-12
Integra LifeSciences USD 265.84M 47.8M 2024-12
J&J USD 15.41B 102M 2024-12
Medtronic USD 5.52B 49M 2025-01
Merit Medical Systems USD 172.98M 15.45M 2024-12
Olympus JPY 167.98B 1.23B 2024-12
Pfizer USD 12.11B 718M 2024-12
STAAR Surgical USD 31.65M 36.84M 2024-12
Stryker USD 4.2B 681M 2024-12
Tandem Diabetes Care USD 157.45M 32.8M 2024-12
Teleflex USD 439.92M 9.74M 2024-12
Terumo JPY 145.12B 5.66B 2024-12
Zimmer Biomet Holdings USD 1.44B 150.9M 2024-12



Merit Medical Systems Beneficio Bruto En Ventas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2025.